# RIPK4

## Overview
RIPK4, or receptor-interacting serine/threonine kinase 4, is a gene that encodes a protein belonging to the serine/threonine kinase family. This protein plays a pivotal role in various cellular processes, particularly in keratinocyte differentiation and epidermal development. The RIPK4 protein is characterized by a conserved N-terminal kinase domain, an intermediate domain, and a C-terminal region with multiple ankyrin repeat domains, which are essential for its structural and functional interactions (De2014A; SÜMER2019Keratin). Functionally, RIPK4 is involved in several signaling pathways, including the Wnt/β-catenin and NF-κB pathways, which are crucial for maintaining epidermal integrity and cellular differentiation (Kwa2014Receptor-interacting; Cuny2021RIPK). Mutations in the RIPK4 gene have been linked to severe developmental disorders such as Bartsocas-Papas syndrome and popliteal pterygium syndrome, underscoring its importance in normal human development (Dinçer2021A; Leslie2015Expanding). Additionally, RIPK4 has been implicated in cancer biology, where its expression levels can influence tumor progression and serve as potential biomarkers (Liu2015Increased; Xu2020Insight).

## Structure
RIPK4 is a serine/threonine kinase that encodes a protein with a molecular weight of 87 kDa, consisting of 784 amino acids. The protein structure includes a conserved N-terminal kinase domain, an intermediate domain, and a C-terminal region containing 11 ankyrin repeat domains (De2014A; SÜMER2019Keratin). The N-terminal kinase domain is crucial for its interaction with other proteins, such as keratin 14 (KRT14), although its kinase activity is not necessary for this interaction (SÜMER2019Keratin). The ankyrin repeats in the C-terminal region may interfere with RIPK4's homodimerization and activation (Cuny2021RIPK).

RIPK4 is involved in various signaling pathways, including those related to keratinocyte differentiation and Wnt signaling. Its kinase activity is essential for certain functions, such as the activation of interferon regulatory factor 6 (IRF6) and the regulation of Wnt target genes (Kwa2014Receptor-interacting; Huang2013Phosphorylation). Post-translational modifications, such as phosphorylation, play a role in regulating RIPK4's activity, although specific phosphorylation sites are not detailed in the provided context. The protein's ability to form homodimers suggests a quaternary structure, which is typical for proteins involved in complex signaling pathways (Cuny2021RIPK).

## Function
Receptor-interacting protein kinase 4 (RIPK4) is a serine/threonine kinase that plays a critical role in keratinocyte differentiation and epidermal development. In healthy human cells, RIPK4 is involved in several signaling pathways, including the protein kinase C (PKC), NF-κB, and Wnt/β-catenin pathways, which are essential for maintaining the integrity of the epidermal barrier (Kwa2014Receptor-interacting; Cuny2021RIPK). RIPK4 directly activates interferon regulatory factor 6 (IRF6), a key transcriptional regulator, promoting the expression of differentiation genes such as GRHL3 and OVOL1, which are crucial for keratinocyte differentiation (Kwa2014Receptor-interacting).

RIPK4 also phosphorylates Dishevelled (DVL) proteins, facilitating Wnt signaling by stabilizing β-catenin, which is important for cell differentiation and proliferation (Huang2013Phosphorylation). The kinase activity of RIPK4 is necessary for these processes, as it influences the phosphorylation and activation of IRF6, leading to its nuclear translocation and subsequent gene regulation (Kwa2014Receptor-interacting). Mutations in RIPK4 can lead to developmental disorders such as Bartsocas-Papas syndrome, highlighting its importance in normal epidermal function (Kwa2014Receptor-interacting). RIPK4's role in these pathways underscores its significance in maintaining skin health and preventing pathological conditions like squamous cell carcinoma (Xu2024Lysophosphatidic).

## Clinical Significance
Mutations in the RIPK4 gene are associated with several severe developmental disorders. Bartsocas-Papas syndrome (BPS) is a rare autosomal recessive disorder linked to homozygous mutations in RIPK4. It is characterized by severe congenital malformations, including craniofacial abnormalities, limb deformities, and popliteal pterygia, often resulting in prenatal or neonatal lethality (Dinçer2021A; Gripp2013Exome). Specific mutations, such as p.Asp161His and p.Gly163Asp, disrupt the kinase domain of RIPK4, impairing its function and leading to the severe phenotypes observed in BPS (Dinçer2021A; Gripp2013Exome).

Popliteal pterygium syndrome (PPS) is another condition associated with RIPK4 mutations, presenting with features like cleft lip/palate and skin webbing. Mutations such as p.Arg618His and p.Ala448Pro have been identified in individuals with PPS, highlighting the gene's role in these syndromes (Leslie2015Expanding).

Altered expression of RIPK4 is also implicated in cancer. In cervical squamous cell carcinoma (CSCC), RIPK4 is upregulated and associated with tumor progression and poor prognosis. Its expression level serves as a potential biomarker for distinguishing high-grade lesions and predicting patient outcomes (Liu2015Increased). RIPK4's role in cancer is complex, acting as both a tumor promoter and suppressor depending on the context (Xu2020Insight).

## Interactions
RIPK4 interacts with several proteins, playing a significant role in various signaling pathways. It interacts with Phosphatidylethanolamine-binding protein 1 (PEBP1), also known as RAF kinase inhibitory protein (RKIP), which mediates the interaction between RIPK4 and the RAF1/MEK/ERK signaling pathway. This interaction is crucial for promoting pancreatic cancer cell migration and invasion (Qi2018RIPK4PEBP1). RIPK4 also interacts with Protein Kinase C Delta (PRKCD) in ovarian cancer cells, where this interaction is essential for RIPK4's oncogenic functions (Jin2021Receptor).

In keratinocyte differentiation, RIPK4 interacts with keratin 14 (KRT14). This interaction is mediated by the N-terminal kinase domain of RIPK4, although its kinase activity is not required for the interaction. RIPK4 and KRT14 colocalize within cells, particularly at keratin filaments associated with perinuclear ring-like structures (SÜMER2019Keratin).

RIPK4 is also involved in the Wnt signaling pathway, where it interacts with Dishevelled (DVL) proteins, specifically DVL2, phosphorylating it at Ser298 and Ser480. This phosphorylation is crucial for the assembly of DVL2 into signaling complexes necessary for effective Wnt3a signaling (Huang2013Phosphorylation).


## References


[1. (Huang2013Phosphorylation) XiaoDong Huang, James C. McGann, Bob Y. Liu, Rami N. Hannoush, Jennie R. Lill, Victoria Pham, Kim Newton, Michael Kakunda, Jinfeng Liu, Christine Yu, Sarah G. Hymowitz, Jo-Anne Hongo, Anthony Wynshaw-Boris, Paul Polakis, Richard M. Harland, and Vishva M. Dixit. Phosphorylation of dishevelled by protein kinase ripk4 regulates wnt signaling. Science, 339(6126):1441–1445, March 2013. URL: http://dx.doi.org/10.1126/science.1232253, doi:10.1126/science.1232253. This article has 129 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.1232253)

[2. (Dinçer2021A) Tuba Dinçer, Evren Gümüş, Bayram Toraman, İdris Er, Gokhan Yildiz, Zafer Yüksel, and Ersan Kalay. A novel homozygous <scp>ripk4</scp> variant in a family with severe <scp>bartsocas‐papas</scp> syndrome. American Journal of Medical Genetics Part A, 185(6):1691–1699, March 2021. URL: http://dx.doi.org/10.1002/ajmg.a.62154, doi:10.1002/ajmg.a.62154. This article has 2 citations.](https://doi.org/10.1002/ajmg.a.62154)

[3. (Liu2015Increased) De-Qing Liu, Fang-Fang Li, Jiang-Bo Zhang, Tie-Jun Zhou, Wen-Qiong Xue, Xiao-Hui Zheng, Yuan-Bin Chen, Xiao-Yu Liao, Lan Zhang, Shao-Dan Zhang, Ye-Zhu Hu, and Wei-Hua Jia. Increased ripk4 expression is associated with progression and poor prognosis in cervical squamous cell carcinoma patients. Scientific Reports, July 2015. URL: http://dx.doi.org/10.1038/srep11955, doi:10.1038/srep11955. This article has 42 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep11955)

[4. (Gripp2013Exome) Karen W. Gripp, Sara Ennis, and Joseph Napoli. Exome analysis in clinical practice: expanding the phenotype of bartsocas–papas syndrome. American Journal of Medical Genetics Part A, 161(5):1058–1063, April 2013. URL: http://dx.doi.org/10.1002/ajmg.a.35913, doi:10.1002/ajmg.a.35913. This article has 22 citations.](https://doi.org/10.1002/ajmg.a.35913)

[5. (Xu2024Lysophosphatidic) Lei Xu, Peter Bajorski, and Brian Poligone. Lysophosphatidic acid down-regulates human ripk4 mrna in keratinocyte- derived cell lines. PLOS ONE, 19(4):e0287444, April 2024. URL: http://dx.doi.org/10.1371/journal.pone.0287444, doi:10.1371/journal.pone.0287444. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0287444)

[6. (De2014A) P De Groote, H T Tran, M Fransen, G Tanghe, C Urwyler, B De Craene, K Leurs, B Gilbert, G Van Imschoot, R De Rycke, C J Guérin, P Holland, G Berx, P Vandenabeele, S Lippens, K Vleminckx, and W Declercq. A novel ripk4–irf6 connection is required to prevent epithelial fusions characteristic for popliteal pterygium syndromes. Cell Death &amp; Differentiation, 22(6):1012–1024, November 2014. URL: http://dx.doi.org/10.1038/cdd.2014.191, doi:10.1038/cdd.2014.191. This article has 35 citations.](https://doi.org/10.1038/cdd.2014.191)

[7. (Qi2018RIPK4PEBP1) Zi-Hao Qi, Hua-Xiang Xu, Shi-Rong Zhang, Jin-Zhi Xu, Shuo Li, He-Li Gao, Wei Jin, Wen-Quan Wang, Chun-Tao Wu, Quan-Xing Ni, Xian-Jun Yu, and Liang Liu. Ripk4/pebp1 axis promotes pancreatic cancer cell migration and invasion by activating raf1/mek/erk signaling. International Journal of Oncology, February 2018. URL: http://dx.doi.org/10.3892/ijo.2018.4269, doi:10.3892/ijo.2018.4269. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ijo.2018.4269)

[8. (Xu2020Insight) Jing Xu, Qichun Wei, and Zhixing He. Insight into the function of ripk4 in keratinocyte differentiation and carcinogenesis. Frontiers in Oncology, August 2020. URL: http://dx.doi.org/10.3389/fonc.2020.01562, doi:10.3389/fonc.2020.01562. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2020.01562)

[9. (Jin2021Receptor) Aihong Jin, Longhui Zhang, Guangguang Fang, and Yinzi Chen. Receptor interacting protein kinase 4 promotes cell proliferation, migration, and invasion in ovarian cancer via targeting protein kinase c delta. Drug Development Research, 83(2):407–415, August 2021. URL: http://dx.doi.org/10.1002/ddr.21871, doi:10.1002/ddr.21871. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/ddr.21871)

[10. (Kwa2014Receptor-interacting) Mei Qi Kwa, Jennifer Huynh, Jiamin Aw, Lianyi Zhang, Thao Nguyen, Eric C. Reynolds, Matthew J. Sweet, John A. Hamilton, and Glen M. Scholz. Receptor-interacting protein kinase 4 and interferon regulatory factor 6 function as a signaling axis to regulate keratinocyte differentiation. Journal of Biological Chemistry, 289(45):31077–31087, November 2014. URL: http://dx.doi.org/10.1074/jbc.m114.589382, doi:10.1074/jbc.m114.589382. This article has 62 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m114.589382)

[11. (Cuny2021RIPK) Gregory D. Cuny and Alexei Degterev. Ripk protein kinase family: atypical lives of typical kinases. Seminars in Cell &amp; Developmental Biology, 109:96–105, January 2021. URL: http://dx.doi.org/10.1016/j.semcdb.2020.06.014, doi:10.1016/j.semcdb.2020.06.014. This article has 53 citations.](https://doi.org/10.1016/j.semcdb.2020.06.014)

[12. (SÜMER2019Keratin) Ceren SÜMER, Asiye Büşra BOZ ER, and Tuba DİNÇER. Keratin 14 is a novel interaction partner of keratinocyte differentiation regulator: receptor-interacting protein kinase 4. TURKISH JOURNAL OF BIOLOGY, 43(4):225–234, August 2019. URL: http://dx.doi.org/10.3906/biy-1904-37, doi:10.3906/biy-1904-37. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3906/biy-1904-37)

[13. (Leslie2015Expanding) Elizabeth J. Leslie, James O’Sullivan, Michael L. Cunningham, Ankur Singh, Steven L. Goudy, Faroug Ababneh, Lamia Alsubaie, Gaik‐Siew Ch’ng, Ingrid M. B. H. van der Laar, A. Jeannette M. Hoogeboom, Martine Dunnwald, Seema Kapoor, Pawina Jiramongkolchai, Jennifer Standley, J. Robert Manak, Jeffrey C. Murray, and Michael J. Dixon. Expanding the genetic and phenotypic spectrum of popliteal pterygium disorders. American Journal of Medical Genetics Part A, 167(3):545–552, February 2015. URL: http://dx.doi.org/10.1002/ajmg.a.36896, doi:10.1002/ajmg.a.36896. This article has 40 citations.](https://doi.org/10.1002/ajmg.a.36896)